Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency
Andrea Ciorba, Piotr H. Skarżyński, Stefano Pelucchi, Stavros Hatzopoulos
Abstract
Aim of this paper is to remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agents against SARS-CoV-2, during the pandemic, should be screened periodically, at least by Otoacoustic Emissions (OAEs) in order to detect early manifestations of possible cochlear ototoxic damages.
Topics & Concepts
HydroxychloroquineChloroquineOtotoxicityPandemicCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyIntensive care medicineImmunologyInternal medicineMalariaOutbreakCisplatinInfectious disease (medical specialty)DiseaseChemotherapyVestibular and auditory disordersHearing, Cochlea, Tinnitus, GeneticsOlfactory and Sensory Function Studies